CASP3 and neoplasm: Thus, the ROS/PKC-ε/caspase 3 pathway is a possible mechanism that CHE uses to inhibit the growth of HCC827 tumor cells, and this finding might provide insight into the mechanism of CHE’s antitumor effect.